Oncology Medical News about BRCA1/2 testing

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

BRCA1/2 testing in patients with newly diagnosed breast cancer
Community Oncology , 10/09/09

Nusbaum R et al. – Initial research demonstrates the utility and feasibility of genetic counseling and testing before definitive surgery in women with newly diagnosed breast cancer. On the basis of the elevated risk of contralateral breast cancer in BRCA1/2 carriers, women with an inherited susceptibility may choose bilateral mastectomy at the time of initial surgical treatment. Thus, timely provision of genetic counseling and testing, which often involve facilitation of a referral to a genetic counselor or genetics team, is critical in this situation.

<< Previous
Positron emission tomography in early detection of relapse in...

Next >>
Many genetically defined ABO subgroups exhibit characteristic...